NSC |
Compound |
Enrichment |
Correlation |
NSC 702313 |
Null |
0.0462077035966084 |
0.41523553 |
NSC 704888 |
Fumaric acid, 2-[5-chloro-3-(2-ethoxy-2-oxoethyl)-2,4-dioxo- 1H,3H-pyrimidinyl]-, diethyl ester |
0.0462077035966084 |
0.47062548 |
NSC 707465 |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.0462077035966084 |
0.22424879 |
NSC 716688 |
Null |
0.0462077035966084 |
-0.19212386 |
NSC 724780 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 |
0.0462077035966084 |
0.51825369 |
NSC 728040 |
2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline |
0.0462077035966084 |
0.31217915 |
NSC 732698 |
1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne |
0.0462077035966084 |
0.28314949 |
NSC 736081 |
4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine |
0.0462077035966084 |
0.36276753 |
NSC 736153 |
Null |
0.0462077035966084 |
0.40913186 |
NSC 743244 |
Null |
0.0462077035966084 |
0.26501994 |